KNOBELMAN DEBORAH has filed 3 insider transactions across 1 company since February 2023.
Most recent transaction: a grant/award of 101000 shares of Senti Biosciences, Inc. ($SNTI) on February 01, 2024.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb. 1, 2024 | Senti Biosciences, Inc. | $SNTI | KNOBELMAN DEBORAH | Chief Financial Officer | A | Common Stock | 101000 | $0.00 | 131,000.0000 | 4,569,900 | 336.67% | 2.21% |
| Feb. 1, 2024 | Senti Biosciences, Inc. | $SNTI | KNOBELMAN DEBORAH | Chief Financial Officer | A | Stock Option (Right to Buy) | 152000 | $0.00 | 152,000.0000 | 4,569,900 | 9999.99% | 3.33% |
| Feb. 1, 2023 | Senti Biosciences, Inc. | $SNTI | KNOBELMAN DEBORAH | Chief Financial Officer | A | Stock Option (Right to Buy) | 130000 | $0.00 | 130,000.0000 | 4,406,137 | 9999.99% | 2.95% |